PMID: 8610642Apr 1, 1996Paper

Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma

American Journal of Clinical Oncology
A A KonskiW Eggleston

Abstract

DNA flow cytometric content analysis (DFCA) and estrogen (ER) and progesterone (PR) receptor levels are reported to be prognostic with regard to the malignant potential of endometrial adenocarcinoma. We retrospectively reviewed the records of 50 patients presenting with endometrial adenocarcinoma between July 1990 and December 1992, to determine the extent of any pathologic features reported at the time of hysterectomy. Patients whose tumors were nondiploid (aneuploid) by flow cytometry generally presented with a higher pathologic stage, higher grade, and more frequent lymph node involvement. In addition, the majority of clear cell and uterine papillary serous (UPS) adenocarcinoma were also nondiploid. Fourteen of 21 ER-positive tumors aneuploid, as were 18 of 37 PR-positive tumors. We also found DNA-A (DNA content aneuploid) patterns frequently associated with tumor characteristics implicated by other authors as related to aggressiveness. Further studies comparing the molecular biology of tumors to their clinicopathologic features and behavior are needed to fully understand the ultimate malignant potential.

References

Jun 1, 1976·American Journal of Obstetrics and Gynecology·P C YoungR E Cleary
Nov 1, 1992·Gynecologic Oncology·D J HetzelK C Podratz
Jul 1, 1992·American Journal of Obstetrics and Gynecology·D Ignar-TrowbridgeJ Boyd
Sep 11, 1991·International Journal of Radiation Oncology, Biology, Physics·A A KonskiR R Dobelbower
Feb 1, 1990·American Journal of Obstetrics and Gynecology·T O WilsonJ M Naessens
Jun 1, 1989·American Journal of Obstetrics and Gynecology·G P SuttonC E Ehrlich
Sep 1, 1989·Gynecologic Oncology·L C BrittonK C Podratz
Sep 1, 1986·Clinical Obstetrics and Gynecology·G S Richardson, D T MacLaughlin
Apr 1, 1988·American Journal of Obstetrics and Gynecology·C E EhrlichW M Alford
Jun 1, 1987·Gynecologic Oncology·S K ChambersP E Schwartz
Oct 1, 1983·American Journal of Obstetrics and Gynecology·J D MartinT L Woodings
Jul 15, 1981·Cancer·G C Lewis, B Bundy
Mar 1, 1982·The American Journal of Surgical Pathology·M HendricksonR Kempson
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·A KonskiW Eggleston
Feb 1, 1993·Gynecologic Oncology·I FujimotoM Takahashi
May 1, 1993·Gynecologic Oncology·F GirardiR Winter
May 1, 1993·Gynecologic Oncology·G S LeiserowitzT C Spelsberg

❮ Previous
Next ❯

Citations

Jul 15, 1996·International Journal of Radiation Oncology, Biology, Physics·A KonskiW Eggleston
Jan 9, 1998·International Journal of Radiation Oncology, Biology, Physics·B C TurnerL D Wilson
Nov 24, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Tomoyuki MiyamotoHiroyuki Kuramoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Related Papers

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
M E Sherman
Genes, Chromosomes & Cancer
Francesca MicciSverre Heim
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Manohar PradhanBjörn Ake Risberg
© 2021 Meta ULC. All rights reserved